Testing effectiveness (Phase 2)Study completedNCT01340053
What this trial is testing
Evaluate the Safety and Efficacy of RDX5791 for the Treatment of Constipation Predominant Irritable Bowel Syndrome (IBS-C)
Who this might be right for
Constipation Predominant Irritable Bowel Syndrome
Ardelyx 186